Within the scope of the expansion of its portfolio, Haspa Beteiligungsgesellschaft für den Mittelstand mbH (Haspa BGM), based in Hamburg, acquired 25% of the shares of MT.DERM GmbH, based in Berlin. The company founder Jörn Kluge remains the majority shareholder and managing director. With this long-term oriented partner from Hamburg, MT.DERM plans to develop further growth potentials as market leader for apparative cosmetics and tattoo products.

MT.DERM, with its own brands such as Cheyenne and amiea, is the world market leader in high-quality products for tattoo and permanent make-up. In addition, the company, which is certified for the manufacture of medical products, is growing internationally with innovative new developments for medical applications such as microneedling. Highest quality, innovation and product safety are the foundation of the successful company development. MT.DERM develops and produces in Germany and today delivers to more than 40 countries worldwide.

Haspa BGM concentrates nationwide on long-term equity investments in medium-sized companies with a turnover of around 10 million euros or more. Silent and open participations are possible. Haspa BGM works in partnership with the entrepreneurs to sustainably support the future viability – and in the event of succession also location retention – over many years.

Transfer Partners was mandated with the complete sales process including the preparation of the transaction-related documents, the research and identification of suitable buyers, the structuring of the due diligence examination and conducting negotiations up to successful completion of the transaction.